CinRx's Series B Round

CinRx raised a round of funding on November 28, 2017.

CinRx is a biopharmaceutical company that is developing therapeutics that address diverse therapeutic areas. CinRx's product candidate portfolio includes new molecular entities (NMEs) with novel drug …

Articles about CinRx's Series B Round: